Best Value Stocks to Buy for February 29th

In this article:

Here are three stocks with buy rank and strong value characteristics for investors to consider today, February 29:

Ultrapar Participações S.A. UGP: This energy and infrastructure company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 31.8% over the last 60 days.

Ultrapar Participacoes S.A. Price and Consensus

Ultrapar Participacoes S.A. Price and Consensus
Ultrapar Participacoes S.A. Price and Consensus

Ultrapar Participacoes S.A. price-consensus-chart | Ultrapar Participacoes S.A. Quote

Ultrapar Participações has a price-to-earnings ratio (P/E) of 19.66 compared with 22.57 for the S&P. The company possesses a Value Score of B.

Ultrapar Participacoes S.A. PE Ratio (TTM)

Ultrapar Participacoes S.A. PE Ratio (TTM)
Ultrapar Participacoes S.A. PE Ratio (TTM)

Ultrapar Participacoes S.A. pe-ratio-ttm | Ultrapar Participacoes S.A. Quote

Honda Motor Co., Ltd. HMC: This automobile company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.3% over the last 60 days.

Honda Motor Co., Ltd. Price and Consensus

Honda Motor Co., Ltd. Price and Consensus
Honda Motor Co., Ltd. Price and Consensus

Honda Motor Co., Ltd. price-consensus-chart | Honda Motor Co., Ltd. Quote

Honda Motor Co has a price-to-earnings ratio (P/E) of 8.45 compared with 21.50 for the S&P. The company possesses a Value Score of A.

Honda Motor Co., Ltd. PE Ratio (TTM)

Honda Motor Co., Ltd. PE Ratio (TTM)
Honda Motor Co., Ltd. PE Ratio (TTM)

Honda Motor Co., Ltd. pe-ratio-ttm | Honda Motor Co., Ltd. Quote

Collegium Pharmaceutical, Inc. COLL: This pharmaceutical company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 6.7% over the last 60 days.

Collegium Pharmaceutical, Inc. Price and Consensus

Collegium Pharmaceutical, Inc. Price and Consensus
Collegium Pharmaceutical, Inc. Price and Consensus

Collegium Pharmaceutical, Inc. price-consensus-chart | Collegium Pharmaceutical, Inc. Quote

Collegium Pharmaceutical has a price-to-earnings ratio (P/E) of 6.19 compared with 21.50 for the S&P. The company possesses a Value Score of A.

Collegium Pharmaceutical, Inc. PE Ratio (TTM)

Collegium Pharmaceutical, Inc. PE Ratio (TTM)
Collegium Pharmaceutical, Inc. PE Ratio (TTM)

Collegium Pharmaceutical, Inc. pe-ratio-ttm | Collegium Pharmaceutical, Inc. Quote

See the full list of top ranked stocks here.

 

Learn more about the Value score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Honda Motor Co., Ltd. (HMC) : Free Stock Analysis Report

Ultrapar Participacoes S.A. (UGP) : Free Stock Analysis Report

Collegium Pharmaceutical, Inc. (COLL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Advertisement